Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver diamine fluoride versus sodium fluoride varnish for tooth hypersensitivity in root caries
ACTRN12624000958583Phase 4Completed
- Sponsor
- bakhtawar amin
- Start
- Jun 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of silver diamine fluoride in carious lesion and Dentinal hypersensitivity (DH) (2 arms), sponsored by bakhtawar amin. Primary endpoint: Tooth hypersensitivity. Started Jun 2022; status: completed.
02
Drugs
silver diamine fluoride
03
Conditions
carious lesionDentinal hypersensitivity (DH)
Beyond the preview
Go deeper on ACTRN12624000958583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000958583.